# Gemini Pharmaceuticals, Inc. – FDA Inspection, May 15, 2026

Source: https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/3c2276f9-a20a-4803-a2e7-9277b1bf2a74
Source feed: FDA_Inspections

> FDA inspection 1317530 of Gemini Pharmaceuticals, Inc., May 15, 2026. Classification: Voluntary Action Indicated (VAI). 7 citations under 21 CFR part 111. Form 483 issued. 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1317530
- Company Name: Gemini Pharmaceuticals, Inc.
- Inspection Date: 2026-05-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Food Composition, Standards, Labeling and Econ
- Product Type: Foods & Cosmetics
- Center: Foods & Cosmetics
- Office Name: New York District Office
- Citation Count: 7

## Related Documents

- FDA Inspection 1175407 - 2022-07-26
- FDA Inspection 1064447 - 2018-08-23
- [FDA Inspection 1041525 - 2018-02-16](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/5f815dde-5720-44ae-a6e5-ab350f64a85e)
- [FDA Inspection 936886 - 2015-06-30](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/6d577591-8391-4524-a2b4-21427df5636b)
- [FDA Inspection 856101 - 2013-11-08](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/a0e9984c-d1de-458a-8f0d-9838d2949911)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/jung-k-kim/50358564-32e0-44d7-9c91-d1ba8885e091)
- [FDA Associated Person](https://www.keypedia.com/people/meredith-p-soehl/52252b59-8f03-41e4-a86f-b92c98048023)

Company: https://www.keypedia.com/companies/gemini-pharmaceuticals-inc/9e83f65c-3863-4ad6-a434-b37d9673ac0f

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d